Publications

MCC Knowledge Products (MCCRP, CBCP, CPDR)

January 1, 2023 – June 12, 2024

 

Total Knowledge Products 

Abstracts                                70

Manuscripts/Publications       16

Manuscript Submissions         32        

Oral Presentations                  5

Posters                                    43

Presentations                          8

Book Chapters                        3

Web Highlights                       2

Total                                        159

 

 

ABSTRACTS (70)

  1. Lovejoy-L, Shriver-C, Ellsworth-C. Breast Cancer in the active-duty servicewoman: does

military service alter breast tumor pathology? 2023 Military Health System Research

Symposium (MHSRS). CBCP.

 

  1. Turza-L, Lovejoy-L, Turner-C, Shriver-C, Ellsworth-R. Eligibility, uptake and response to

germline genetic testing in women with DCIS. 2023 Military Health System Research

Symposium (MHSRS). CBCP

 

  1. Darmon-S, Park-A, Lovejoy-L, Shriver-C, Zhu-K, Ellsworth-R. Relationship between

cigarette smoking and cancer pathology and survival among breast cancer patients. 2023

Military Health System Research Symposium (MHSRS). CBCP

 

  1. Petyuk-V., Pucilowska-J., Leonard-B., Schepmoes-A., Fillmore-T., Shi-T., Zhu-K.,

Forsberg-J., Potter-B., Anderson-A., Shriver-C., Rodland-K., Liu-T. Mining the DoD Serum

Repository for Protein Biomarkers of Bone Metastasis Using Longitudinal Analysis and

Machine Learning. 2023 Military Health System Research Symposium (MHSRS). MCCRP

 

  1. Eaglehouse-Y., Shriver-C., Lin-J., Bytnar-J., Darmon-S., McGlynn-K., Zhu-K. MilCanEpi:

Increased Capability for Cancer Care Research in the Department of Defense. 2023 Military

Health System Research Symposium (MHSRS). MCCRP

 

  1. Eaglehouse-Y., Darmon-S., Gage-M., Shriver-C., Zhu-K. Factors Related to Survival for

Patients with Surgically Non-Resected Pancreatic Adenocarcinoma in the U.S. Military

Health System. 2023 Military Health System Research Symposium (MHSRS). MCCRP

 

  1. Eaglehouse-Y., Darmon-S., Park-A., Shriver-C., Zhu-K. Using Population Data to Inform

Treatment Guidelines: A Study of Pancreatic Cancer Treatment and Overall Survival in the

U.S. Military Health System. 2023 Military Health System Research Symposium (MHSRS).

MCCRP

 

  1. Lin-J, Shriver-C, Zhu-K. Post-diagnosis Statin use and Survival among Head and Neck

Cancer Patients: A Cohort Study in the U.S. Military Health System. 2023 Military Health

System Research Symposium (MHSRS). MCCRP

 

  1. Lin-J, Shriver-C, Zhu-K. Association of health care system and survival among patients with

head and neck cancer. 2023 Military Health System Research Symposium (MHSRS).

MCCRP

 

  1. Bytnar-J, Enewold-L, Shriver-C, Zhu-K. Racial disparities in papillary thyroid cancer

incidence: Comparison of the military with the general population by gender, stage, and

tumor size. 2023 Military Health System Research Symposium (MHSRS). MCCRP

 

  1. Nealeigh-M, Shriver-C, Ellsworth-R. Evaluation of racial disparities in DCIS recurrence

among US black and white women in an equal-access healthcare system. 2023 Military

Health System Research Symposium (MHSRS). CBCP

 

  1. Seagal-A., Deyarmin-B., Ciubotaru-A., Blake-L., Murtha-K., Wells-J., Greenspan-R.,

Campbell-L., Stratton-J., Wolf-N., Shriver-C., Kvecher-L., Hu-H. Optimization and Data

Visualization of Applied Proteogenomics Organizational Learning and Outcomes (APOLLO)

Pathology Data. 2023 Military Health System Research Symposium (MHSRS). MCCRP.

 

  1. Bateman-N, Abulez-T, Schafer-C, Conrads-K, Hood-B, Zhang-X, Sesterhenn-I, Dalgard-C,

Wilkerson-M, Dobi-A, Petrovics-G, Shriver-C, Chesnut-G, Conrads-T, Tan-SH. A Protein

Expression Signature of TMPRSS2_ERG Gene Fusion and ERG Protein Overexpression in

Prostate Cancer. 2023 Military Health System Research Symposium (MHSRS). MCCRP.

 

  1. Deyarmin-B, Blackburn-H, Miller-K, Kane-K, Cannada-M, Larson-C, Murtha-K, Kvecher-

L, Wolf-N, Kildee-M, Sakura-S, Wells-J, Hooke-J, Greenspan-R, Zingmark-R, Hu-H,

Shriver-C, Somiari-S. Murtha Cancer Center Research Program Efforts to Provide Precision

Medicine for the Military through Participation in the Oncology Research Information

Exchange Network (ORIEN). 2023 Military Health System Research Symposium (MHSRS).

MCCRP.

 

  1. Shuss-S, Sturtz-L, Rummel-S, Blackburn-H, Kane-J, Cannada-M, Deyarmin-B, Miller-K,

Stratton-S, APOLLO Research Network, Shriver-C, Hu-H. Exploring Beyond Sample

Identification to Strengthen the Role of Molecular Quality Control in the APOLLO Program.

2023 Military Health System Research Symposium (MHSRS). MCCRP.

 

  1. Melikant-B, Stratton-J, Chu-A, Cronin -K, Eley-G, Maddy-A, Campbell-L, APOLLO

Research Network, Shriver-C, Kvecher-L, Hu-H. An Approach to Researching Project

Management Software and Increasing reliability of Atlassian Confluence. 2023 Military

Health System Research Symposium (MHSRS). MCCRP.

Russo-M, Kumar-P, Liu-J,Deyarmin-B, Murtha-K, Wells-J, Wolf-N, Somiari-S, Kvecher-L,

Hu-H, Shriver-C, Lin-X. Genomic and Transcriptomic Analysis of Matched Metastatic

Breast Cancer in a Multi-Network Cohort. 2023 ORIEN Scientific Retreat. MCCRP.

 

  1. Bowling-G, Beck-K, Egtedari-C, Mecca-D, Malhotra-S, Su-X, Dobi-A, Eldhose-B. Precision

Medicine for the Treatment of ERG Positive Prostate Cancer. 2023 Military Health System

Research Symposium (MHSRS). CPDR

 

  1. Lei-J., Katz-J., Somiari-S., VH-T., mCasey-W., Lee-J., Shriver-C. Opportunities for Remote

Sampling Technologies to Enable Comprehensive Biobanking of Military Population

towards Digitizing Biology. 2023 Military Health System Research Symposium (MHSRS).

MCCRP

 

  1. Patkar-S., Harmon-S., Sesterhenn-I., Lis-R., Merino-M., Young-D., Brown-T., Greenfield-

K., McGeeney-J., Elsamanoudi-S., Tan-SH., Jiang-J., Petrovics-G., Dobi-A., Rentas-F.,

Chesnut-G., Choyke-P., Turkbey-B., Moncur-J. Machine Learning Algorithms Development

with Joint Pathology Center and Center for Prostate Disease Research Data Predict Prognosis

of Prostate Cancer. 2023 Military Health System Research Symposium (MHSRS). CPDR

 

  1. McNeary-Garvin-A., Linday-H., Rabbette-M., Sunderland-K., Garcia-A., Gonzales-D.,

Brown-A., Hudson-N., Claxton-R., Nguyen-M., Estrada Veras-J., DeStefano-C., Rigor-R.,

Huffman-S., Milner-M., Phan-L., Williams-B. Personalized cancer risk assessment and

genetic counseling of USAF Aircrews flying at high altitudes. 2023 Military Health System

Research Symposium (MHSRS). MCCRP.

 

  1. Babcock-K., Kohaar-I., Petrovics-G., Chesnut-G., Tan-SK., Dobi-A. LSAMP Re-Expression

Inhibits Circulating Tumor Cell Burden in a Prostate Cancer Xenograft Model. 2023 USU

Research Day. CPDR

 

  1. Borbiev-T., Bejar-K., Young-D., Song-Y., Jiang-J., Kagan-J., Srivastava-S., Hernandez-J.,

Chesnut-G., Sesterhenn-I., Leach-R., Petrovics-G., Kohaar-I. Prostate Cancer Biomarkers of

Biochemical Recurrence in low-Risk Prostate Cancer Patients. 2023 USU Research Day.

CPDR

 

  1. Beck-K., Bowling-G., Eghtedari-C., Dobi-A., Su-X., Eldhose-B. ERGi-USU Selectively

Inhibit ERG Positive Prostate Cancer through ATF3 mediated Ferroptosis. 2023 USU

Research Day. CPDR

 

  1. Lin-J, Shriver-C, Zhu-K. Post-diagnosis Statin use and Survival among Head and Neck

Cancer Patients: A Cohort Study in the U.S. Military Health System. 2023 American

Association for Cancer Research (AACR). MCCRP.

 

  1. Wilkerson-M., Kounelis-Wuillaume-S., Alba-C., Franks-T., Doughty-M., Kortum-R.,

Browning-R., Dalgard-C., Shriver-C. Tumor microenvironment differences between lung

cancer subtypes revealed by spatial transcriptomics. 2023 American Association for Cancer

Research (AACR).  MCCRP.

 

  1. Sardar-S., Ravindranath-L., McNair-C., Chand-S., Yuan-W., Bogdan-D., Welti-J., Sharp-A.,

Schiewer-M., Butler-L., de Bono-J., Frese-K., Brooks-N., Pegg-N., Knudsen-K., Shafi-A.

Targeting the CBP/p300 Axis Regulates DNA Damage Repair in Lethal Prostate Cancer.

2023 GRC (Gordon Research Conference) Hormone Dependent Cancers. CPDR

 

  1. Borbiev-T., Bejar-K., Young-D., Song-Y, Jiang-J., Kagan-J., Srivastava-S., Hernandez-J.,

Chesnut-G., Sesterhenn-I., Leach-R., Petrovics-G., Kohaar-I. Prostate Cancer Biomarkers of

Biochemical Recurrence in Low-risk prostate Cancer patients. 2023 USU Research Day.

CPDR

 

  1. Smith-M., Ravindranath-L., Shafi-A. The Circadian Cryptochrome, CRY1, Displays

Disease-Specific Functions in Prostate Cancer. 2023 GRC (Gordon Research Conference)

Hormone Dependent Cancers. CPDR

 

  1. Kumar-P., Lin-X., Liu-T., Sturtz-L., Gritsenko-M., Petyuk-V., Sagendorf-T., Deyarmin-

B., Lui-J., Kumar-AP., Wang-G., McDermott-J., Shukla-A., Moore-R., Monroe-M.,

Webb-Robertson-BJ., Hooke-JA., Fantacone-Campbell-L., Mostoller-B., Kvecher-L.,

Kane-J., Melley-J., Somiari-S., Soon Shiong-P., Smith-R., Mural R., Rodland-K.,

Shriver-C., Kovatich-A., Hu, H. Proteogenomic characterization of non-luminal A versus

luminal A breast cancer tumor cells enriched by laser microdissection. San Antonio

Breast Cancer Symposium (SABCS). CBCP

 

  1. Kumar-P., Liu-J., Soltis-A., Bateman-N., Chen-Q., Sturtz-L., Deyarmin-B., Pierobon-M.,

Abulez-T., Kumar-AP., Zhang-X., Nguyen-T., Yan-C., Hu-Y., Guion-K., Hooke-J.,

Kovatich-A., Campbell-L., Mostoller-B., Kvecher-L., Somiari-S., Steeg-P., Rajagopal-S.,

Darcy-K., Lee-J., Dalgard-C., Conrads-T., Petricoin-E., Meerzaman-D., Wilkerson-M.,

APOLLO Research Network, Lin-X., Shriver-C., Lipkowitz-S., Hu-H. Proteogenomic

characterization of primary invasive breast tumors from young women compared to

matched tumors from older women. San Antonio Breast Cancer Symposium (SABCS).

CBCP

 

  1. Sgrignoli-R., Robertson-I., Kazandijan-D., Landgren-O., Darmon-S., DeStefano-C. Long

Term Cancer Risk of U.S. Service Members Exposed to Burn Pits During Military

Deployment to Iraq from 2006-2008: A Retrospective Cohort Study. 2023 American

Society of Hematology (ASH) Annual Meeting and Exposition. MCCRP

 

  1. Janas-T., Stopsack-K. Schmidt-D., Ma-D., Li-Z., Heiden-M., Penny-K., Scheet-P.,

Lotan-T., Amon-A., Mucci-L., Su-X. Aneuploidy-associated SQLE gain promotes

prostate cancer aggressiveness by altering lipid metabolism. 2023 Hormone Dependent

Cancers Gordon Research Conference (GRC). CPDR

 

  1. Bytnar-J., McGlynn-K., Shriver-C., Zhu-K. Incidence Rates of Bladder and Kidney

Cancers among U.S. Military Servicemen: Comparison with the Rates in the General

U.S. Population. 2024 Association of Military Surgeons of the United States (AMSUS)

Annual Meeting. MCCRP

 

  1. Kazandijan-D., DeStefano-C., Dew-A., Hill-E., Thoren-K., Landgren-O. High Prevalence

of Monoclonal Gammopathy of Undetermined Significance in US Military Service

Members Deployed to either Europe or Iraq Irrespective of Reported Burn Pit and Toxic

Smoke Exposure. American Society of Hematology Annual Meeting. MCCRP

 

  1. Lin-J., Orestes-M., Shriver-C., Zhu-K. Race and survival among patients with head and

neck cancer: comparison of the Military Health System and the general population. 2024

Association of Military Surgeons of the United States (AMSUS) Annual Meeting.

MCCRP

 

  1. Bytnar-J., Enewold-L., Shriver-C., Zhu-K. Incidence of papillary thyroid cancer:

Comparison of the military and the general population by race and tumor stage/size. 2024

Association of Military Surgeons of the United States (AMSUS) Annual Meeting.

MCCRP

 

  1. German-B., Morel-K., Burkhart-D., Noel-T., Boufaied-N., Dezem-F., Qui-X., Long-H., Baca-S., Freedman-M., Beltran-H., Sweeney-C., Plummer-J., Knott-S., Che-S., Labbé-D., Ellis-L. EZH2 regulates cell identity by inducing alternate transcriptional programs dependent on activation of translation and regulation of RNA maturation. 2024 Annual Multi-Institutional Prostate Cancer Program Retreat, SPORE. CPDR

 

  1. Bytnar-J., McGlynn-K., Kern-S., Shriver-C., Zhu-K. Incidence Rates of Bladder and Kidney Cancers among U.S. Military Servicemen: Comparison with the Rates in the General U.S. Population. 2024 American Association for Cancer Research (AACR) Annual Meeting. MCCRP

 

  1. Sadar-S., Ravindranath-L., McNair-C., Chand-S., Yuan-W., Bogdan-D., Welti-J., Sharp-A., Schiewer-M., Butler-L., Bono-J., Frese-K., Brooks-N., Pegg-N., Knudsen-K., Shafi-A.  Targeting the AR Co-activator CBP/p300 Axis in Castration Resistant Prostate Cancer Impacts DNA Damage Repair Function. 2024 AACR Special Conference: DNA Damage Repair: From Basic Science to Future Clinical Application. CPDR

 

  1. LaMorte-J., Bateman-N., Conrads-T., Browning-R., Shriver-C., Kortum-R., Wilkerson-M. Divergent proteogenomic gene expression is driven by microenvironment across tumor types. 2024 American Association for Cancer Research (AACR) Annual Meeting. MCCRP

 

  1. Liu-J., Lin-X., Shriver-C., Hu-H. Treatment resistance and survival prediction using a machine learning gene expression signature in pancreatic adenocarcinoma. 2024 American Association for Cancer Research (AACR) Conference. CBCP

 

  1. Sadar-S., Ravindranath-L., McNair-C., Chand-S., Yuan-W., Bogdan-D., Welti-J., Sharp-A., Schiewer-M., Butler-L., Bono-J., Frese-K., Brooks-N., Pegg-N., Knudsen-K., Shafi-A. Targeting the CBP/p300 Axis in Lethal Prostate Cancer Impacts DNA Repair. 2024 Prostate Cancer SPORE Meeting – LA, California. CPDR

 

 

  1. Schafer-C., Abulez-T., Zhang-X., Young-D., Fox-J., Conrads-K., Hood-B., Sukumar-G., Nousome-D., Shafi-A., Dobi-A., Petrovics-G., Jiang-J., Elsamanoudi-S., Cullen-J., Dalgard-C., Wilkerson-M., Bateman-N., Conrads-T., Sesterhenn-I., Shriver-C., Chesnut-G., Tan-S.  Proteogenomic landscape of prostate cancers from patients of African and European ancestries highlight novel signatures of aggressive disease. 2024 American Association for Cancer Research (AACR) Conference. CPDR.

 

  1. Eaglehouse-Y., Darmon-S., Shriver-C., Zhu-K. Using DoD Big Data to address cancer health disparities: Comparing racial-ethnic groups in receipt of treatment(s) for papillary thyroid cancers. 2024 Military Health System Research Symposium (MHSRS). MCCRP

 

 

  1. Eaglehouse-Y., Darmon-S., Shriver-C., Zhu-K. Comparing Black and White Patients with Rectal Cancer in Treatment and Outcomes in the U.S. Military Health System using the Department of Defense’s Big Data on Cancer. 2024 Military Health System Research Symposium (MHSRS). MCCRP

 

  1. German-B. EZH2 regulates cell identity in neuroendocrine-like prostate cancer by inducing alternate transcriptional programs dependent on activation of translation and regulation of RNA maturation. EMBO Workshop on Chromatin Biology in Cancer April 23-26, 2024 (Singapore, SG). CPDR

 

  1. Lin-J., Shriver-C., Zhu-K. Differences in Survival between Black and White Patients with Lung Cancer: Comparison of Data from the DoD Central Cancer Registry (CCR) and the National Surveillance, Epidemiology and End Results (SEER) Program. 2024 Military Health System Research Symposium (MHSRS). MCCRP

 

  1. Lin-J., Shriver-C., Zhu-K. Post-diagnosis statin use and survival among lung cancer patients: A study based on MilCanEpi, linked database of the DoD Central Cancer Registry (CCR) and MHS Data Repository (MDR). 2024 Military Health System Research Symposium (MHSRS). MCCRP

 

  1. Clendinen-C., Jain-R., Lalli-P., Eder-J., Liu-T., Kyle-J. Novel Approach to the Detection and Identification of Polycyclic Aromatic Hydrocarbons. 2024 Military Health System Research Symposium (MHSRS). MCCRP

 

  1. Jain-R., Sarkar-S., Zheng-X., Lali-P., Clenden-C., Melchior-J., Liu-T., Kyle-J. PFAS association in human blood serum. 2024 Military Health System Research Symposium (MHSRS). MCCRP

 

  1. Bytnar-J., Shriver-C., Zhu-K. Soft Tissue Sarcoma Incidence among U.S. Military Servicemen: Comparison with the Rates in the General U.S. Population. 2024 Military Health System Research Symposium (MHSRS). MCCRP

 

  1. Bytnar-J., McGlynn-K., Kern-S., Shriver-C., Zhu-K. Incidence Rates of Bladder and Kidney Cancers among U.S. Military Servicemen: Comparison with the Rates in the General U.S. Population. 2024 Military Health System Research Symposium (MHSRS). MCCRP

 

  1. Miller-K., Blackburn-H., Deyarmin-B., Kane-J., Cannada-M., Shuss-S., Sturtz-L., Raj-Kumar-PK., Hu-H., Shriver-C., Gaskin-Z., Somiari-S. The Development of Workflows to Determine Sources of Potential Sample Mismatches throughout a Biorepository: A Case Study. 2024 Military Health System Research Symposium (MHSRS). CBCP

 

  1. Kumar-A., Raj-Kumar-P., Liu-J., Deyarmin-B., Mostoller-B., Larson-C., Blackburn-H., Teeter-D., Russo-M., Fantacone-Campbell-L., Hooke-J., Kovatich-A., Shriver-C., Hu-H., Lin-X. Identification of Blood Protein Biomarkers Associated with Breast Cancer Recurrence. 2024 American Society of Clinical Oncology (ASCO) Annual Meeting. CBCP

 

  1. Raj-Kumar-P., Liu-J., Soltis-A., Bateman-N.,Chen-Q., Sturtz-L., Deyarmin-B., Pierobon-M., Abulez-T., Praveen-Kumar-A., Zhang-X., Nguyen-T., Yan-C., Hu-Y., Guion-K., Hooke-J., Kovatich-A., Fantacone-Campbell-L., Mosteller-B., Kvecher-L., Somiari-S., Steeg-P., Rajagopal-P., Darcy-K., Lee-J., Dalgard-C., Conrads-T., Petricoin-E., Meerzaman-D., Wilkerson-M., APOLLO Research Network, Lin-X., Shriver-C., Lipkowitz-S., Hu-H. Proteogenomic characterization of primary invasive breast tumors from young women compared to matched tumors from older women. 2024 Military Health System Research Symposium (MHSRS). CBCP

 

  1. Liu-J., Lin-X., Shriver-C., Hu-H. Treatment Resistance and Survival Prediction Using a Machine Learning Gene Expression Signature in Pancreatic Adenocarcinoma. 2024 Military Health System Research Symposium (MHSRS). MCCRP

 

  1. Maddy-A., Mostoller-B., Murtha-K., Kildee-M., Rojas-L., Fitmaurice-S., Jonsson-T., Lee-J., Kvecher-L., Shriver-C., Hu-H. A Data Tracking System for the PROject for Military Exposures and Toxin History Evaluation in US servicemembers (DTS-PROMETHEUS). 2024 Military Health System Research Symposium (MHSRS). CBCP

 

  1. Jordan-R., Shuss-S., Sturtz-L., Stratton-J., Lin-X., The APOLLO Research Network, Kvecher-L., Shriver-C., Hu-H. Incorporating Gender and Race Verifications to Increase Quality Control Efficiency. 2024 Military Health System Research Symposium (MHSRS). CBCP

 

  1. Seagal-A., Deyarmin-B., Murtha-K., Wells-J., Greenspan-R., Campbell-L., Stratton-J., Mostoller-B., Ciubotaru-A., Wolf-N., APOLLO Research Network, Kvecher-L., Shriver-C., Hu-H.  Integrated Software Solution for Access and Analysis of Cancer-Related Histology Slide Images Stored and Managed in the Aperio System for the APOLLO Network. 2024 Military Health System Research Symposium (MHSRS). CBCP

 

  1. Schafer-C., Abulez-T., Zhang-X., Young-D., Fox-J., Conrads-K., Hood-B., Sukumar-G., Nousome-D., Shafi-A., Dobi-A., Petrovics-G., Jiang-J., Elsamanoudi-S., Cullen-J., Dalgard-C., Wilkerson-M., Bateman-N., Conrads-T., Sesterhenn-I., APOLLO Research Network, Shriver-C., Chesnut-G., Tan-SH. Proteogenomic analyses of prostate cancers from patients of African and European ancestries in a military patient cohort identify novel signatures of aggressive disease. 2024 Military Health System Research Symposium (MHSRS). CPDR

 

  1. Borbiev-T., Kohaar-I., Siddiqui-I., Chesnut-G., Petrovics-G., Wei-J. Urine Exosomal RNA Signatures Discriminate Gleason Groups at Initial Biopsy for Prostate Cancer. 2024 Military Health System Research Symposium (MHSRS). CPDR

 

  1. Borbiev-T., Kohaar-I., Siddiqui-I., Chesnut-G., Petrovics-G., Wei-J. Urine Exosomal RNA Signatures Discriminate Gleason Groups at Initial Biopsy for Prostate Cancer. 2024 USU Research Day. CPDR

 

  1. Morris-A. Havens-L., Hartley-K., Lei-J., Katz-J., Casey-W., Lee-J., Shriver-C., Vincent-Hall-T. Exposure Screening and Biorepository Opportunities for Capillary Blood Draws – Test Case: PFAS analysis and the OneDraw Sampling Unit. 2024 Military Health System Research Symposium (MHSRS). MCCRP

 

  1. Casey-W., Kyle-J., Embry-M., Sake-C., Liu-T., Somiari-S. Lee-J., Shriver-C., Katz-J. Development and Characterization of a Set of Internal Standards, Chemical Libraries and Long Term Reference Samples to Enable Service-Member Related Exposure Studies. 2024 Military Health System Research Symposium (MHSRS). MCCRP

 

  1. Sake-C., Chilakala-S., Yoon-A., Somiari-S., Miller-K., Blackburn-H., Hu-H., Lee-J., Shriver-C., Katz-J. Evaluation of Red Blood Cell Depletion in Blood Fractionation Workflows Towards A Leukocyte Based Exposure Assay. 2024 Military Health System Research Symposium (MHSRS). MCCRP

 

  1. Janas-T., Stopsack-K., Schmidt-D., Ma-D., Li-Z., Heiden-M., Penny-K., Scheet-P., Lotan-T., Amon-A., Mucci-L., Su-X. Aneuploidy-associated SQLE gain promotes prostate cancer aggressiveness by altering lipid metabolism. 2024 UCLA SPORE Conference. CPDR

 

  1. Russo-M., Lin-X., Shriver-C., Hu-H. Genomic Adaptations for Metastatic Progression in Breast Cancer. 2024 International Conference on Intelligent Systems for Molecular Biology (ISMB). CPDR

 

  1. Chen-B., Lin-X., Shriver-C., Hu-H., Raj-Kumar-P. Development and release of PCA-PAM50 as a CRAN package for enhanced Breast Cancer Subtyping. 2024 International Conference on Intelligent Systems for Molecular Biology (ISMB). CBCP

 

  1. German-B., Morel-K., Burkhart-D., Noel-T., Boufaied-N., Dezem-F., Qui-X., Long-H., Ku-S., Goodrich-D., Baca-S., Freedman-M., Beltran-H., Sweeney-C., Knott-S., Plummer-J., Labbe-D., Ellis-L.  EZH2 regulates cell identity in neuroendocrine-like prostate cancer by inducing alternate transcriptional programs dependent on activation of translation and regulation of RNA maturation. 36th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics, 23-25 October. CPDR

 

  1. Hu-M., Lu-J., Deyarmin-B., Mostoller-B., Kovatich-A., Shriver-C., Hu-H., Lin-X., Sturtz-L. Profiling Racial Differences in Breast Cancer with Plasma Metabolomics. 2024 Federation of American Societies for Experimental Biology (FASEB) Conference, Molecular Metabolism: Cells and Systems. CBCP

 

PRESENTATIONS (8)

  1. Zhu, K. Overview of Data-Based Cancer Research in Health Equity by Epidemiology Team, Murtha Cancer Center Research Program (MCCRP). 2024 Association of Military Surgeons of the United States (AMSUS) Annual Meeting. MCCRP

 

  1. Eaglehouse, Y. Health Equity and Outcomes in Cancer Care within the Department of Defense. 2024 Association of Military Surgeons of the United States (AMSUS) Annual Meeting. MCCRP

 

  1. Dobi-A. Health Equity in DoD Prostate Cancer: Quality of life, choice of treatment, and patient reported outcomes. 2024 Association of Military Surgeons of the United States (AMSUS) Annual Meeting. CPDR

 

  1. Petrovics-G. Health Equity: Military versus Civilian. 2024 Association of Military Surgeons of the United States (AMSUS) Annual Meeting. CPDR

 

  1. Lin, J. Health Equity and Cancer Outcomes: Comparison of Survival between Military Health System Beneficiaries and the U.S. General Population. 2024 Association of Military Surgeons of the United States (AMSUS) Annual Meeting. MCCRP

 

  1. German-B. EZH2 regulates cell identity in neuroendocrine-like prostate cancer by inducing alternate transcriptional programs dependent on activation of translation and regulation of RNA maturation. EMBO Workshop, Chromatin Biology in Cancer 2024, April 23-26, Singapore. CPDR

 

  1. Chesnut-G. Center for Prostate Disease Research – Murtha Cancer Center Research Program. American Urological Association (AUA) Annual Conference 2024. CPDR

 

  1. Natale-K., Shriver-C., Lombardo-J. Murtha Cancer Center Research Program on behalf of the Department of Defense's ACCESS Hub. IN-person meeting of the NCI Cancer Screening Research Network. MCCRP

 

MANUSCRIPT SUBMISSIONS (32)

  1. Nations-J, Lin-J, Park-A, Antevil-J, Shriver-C, Zhu-K. Pulmonary Hypertension and

Survival among Non-Small Cell Lung Cancer Patients. JAMA Oncology. MCCRP

 

  1. Babcock-K., Sreenath-T., Kohaar-I., Xavier-C., Young-D., Srivastava-S., Petrovics-G.,

Chesnut-G., Tan-SH., Dobi-A. LSAMP inhibits tumor growth and metastatic spread by

modulating adhesion through specific RTKs in prostate cancer. Cancer Discovery, EBio

Medicine. CPDR

 

  1. Patkar-S., Harmon-S., Sesterhenn-I., Lis-R., Merino-M., Young-D., Brown-T., Greenfield-

K., McGeeney-J., Elsamanoudi-S., Tan-SH., Jiang-J., Petrovics-G., Dobi-A., Rentas-F.,

Chesnut-G., Choyke-P., Turkbey-B., Moncur-J. A Selective CutMix Approach Improves

Generalizability of Deep Learning-based Grading and Risk assessment of Prostate Cancer.

Medical Imaging using Deep Learning (MIDL) Conference. CPDR

 

  1. Eaglehouse-Y., Darmon-S., Gage-M., Shriver-C., Zhu-K. Factors Related to Survival in

Surgically Non-resected Pancreatic Adenocarcinoma. Journal of Clinical Oncology.

MCCRP

  1. Eaglehouse-Y., Darmon-S., Park-A., Shriver-C., Zhu-K. Time Between Pancreatic Cancer

Diagnosis and Treatment Initiation and Overall Survival in a Universal Health System.

Annals of Oncology. MCCRP

 

  1. Turza-L., Shriver-C. Something to Dye For: Towards Better Breast Lumpectomy Margins.

New England Journal of Medicine (NEJM) Evidence. MCCRP

 

  1. Bataba-E., Babcock-K., Isensee-K., Eldhose-B., Kohaar-I., Chestnut-G., Dobi-A. Germline

mutations and ancestry in prostate cancer in brief. International Journal of Molecular

Sciences. CPDR

 

  1. Kumar-AP., Vicente-D., Liu-J., Raj-Kumar-KP., Deyarmin-B., Lin-X., Shriver-C., Hu-H.

Association of clinicopathologic and molecular factors with the occurrence of positive

margins in breast cancer. Breast Cancer Research and Treatment (Springer) Journal.

CBCP

 

  1. Lin-J., Orestes-MI., Shriver-CD., Zhu-K. Post-diagnosis Statin Use and Survival among

Head and Neck Cancer Patients: A Cohort Study in a Universal Health Care System.

Head and Neck (Journal). MCCRP

 

  1. Lin-J., Orestes-MI., Shriver-CD., Zhu-K. Differences in Survival between Black and

White Patients with Head and Neck Squamous Cell Carcinoma: Comparison of Data

from the DoD Central Cancer Registry and SEER. Oral Oncology (Journal). MCCRP

 

  1. Eaglehouse-Y., Darmon-S., Chestnut-G., Shriver-C., Zhu-K. Comparing Black and

White Patients in Treatment and Survival of Advanced Prostate Cancer in an Equal

Access Health System. Journal of Urology. MCCRP

 

  1. Ghandadi-M., Dobi-A., Malhorta-S. RIO family of kinases: emerging targets and

biomarkers in malignancies. Frontiers in Oncology (Journal). CPDR

 

  1. Patkar-S., Harmon-S., Sesterhenn-I., Lis-R., Merino-M., Young-D., Thomas Brown-G.,

Greenfield-K., McGeeney-J., Elsamanoudi-S., Tan-SH., Jiang-J., Petrovics-G., Dobi-A.,

Rentas-F., Chesnut-G., Choyke-P., Turkbey-B., Moncur-J. A Selective CutMix Approach

Improves Generalizability of Deep Learning-based Grading and Risk assessment of

Prostate Cancer. Modern Pathology (Journal). CPDR

 

  1. Bytnar-J., Enewold-L., Shriver-C., Zhu-K. Incidence of papillary thyroid cancer:

Comparison of the military and the general population by race and tumor stage/size.

Cancer Epidemiology, Biomarkers & Prevention Journal. MCCRP

 

  1. Kumar-P., Liu-J., Soltis-A., Bateman-N., Chen-Q., Sturtz-L., Deyarmin-B., Pierobon-M., Abulez T., Kumar-AP., Zhang-X., Nguyen-T., Yan-C., Hu-Y., Guion-K., Hooke-J., Kovatich-A., Campbell-L., Mostoller-B., Kvecher-L., Somiari-S., Steeg-P., Rajagopal-S., Darcy-K., Lee-J., Dalgard-C., Conrads-T., Petricoin-E., Meerzaman-D., Wilkerson-M., APOLLO Research Network, Lin-X., Shriver-C., Lipkowitz-S., Hu-H. Proteogenomic characterization of invasive breast tumors in young women. Cell Reports Medicine Journal. CBCP

 

  1. Bandi-L., Lin-J., Shriver-C., Chestnut-G., Zhu-K. Comparative Trends in the Distribution of Prostate Cancer Stage at Diagnosis in the Department of Defense Cancer Registry and the Surveillance, Epidemiology, and End Results data, 2004-2014. Military Medicine Journal. MCCRP

 

  1. Bytnar-J., McGlynn-K., Kern-S., Shriver-C., Zhu-K. Incidence Rates of Bladder and Kidney Cancers among U.S. Military Servicemen: Comparison with the Rates in the General U.S. Population. Cancer Journal. MCCRP

 

  1. Borbiev-T., Kohaar-I., Petrovics-G. Clinical Biofluid Assays for Prostate Cancer. Cancers (MDPI Scientific Journal). CPDR

 

  1. Fox-J., Latham-K., Darmon-S., Eaglehouse-Y., Bytnar-J., Shriver-C., Zhu-K. Immediate breast reconstruction after mastectomy for cancer among U.S. Military Health System beneficiaries. Journal of the American College of Surgeons (JACS). MCCRP

 

  1. Higa-N., Limb-A., Hennes-V., Rivera-A., Nevarez-R., Kolatkar-A., Tweed-C., Riker-A., Lee-Y., Tafra-L., Shriver-C., Kuhn-P., Hicks-J. Simultaneous expression of epithelial and immune cell markers in circulating tumor cells from a stage 4 breast cancer patient. Science Translational Medicine Journal. MCCRP

 

  1. Eaglehouse-Y., Darmon-S., Shriver-C., Zhu-K. Racial-Ethnic Comparison of Treatment for Papillary Thyroid Cancer in an Equal Access Health System. Thyroid Journal. MCCRP

 

  1. German-B., Petkovich-D., Ellis-L. Epigenetic Remodeling of the Myeloid Landscape of the Cancer Tumor Microenvironment. "Comprehensive cancer inflammation and immunity" for the Elsevier group. CPDR

 

  1. German-B., Singh-j., Fonseca-M., Burkhart-D., Sheahan-A., Bergom-H., Morel-K., Beltran-H., Hwang-J., Lawrenson-K., Ellis-L. MYBL2 drives prostate cancer plasticity and identifies CDK2 as a therapeutic vulnerability in RB1-loss and neuroendocrine prostate cancer. Cancer Research Communications Journal. CPDR

 

  1. Nelson-N., Burke-S., Cappelli-L., Matlack-L., Smith-A. Francois-N., Lombardo-J., Shah-Y., Wen-K., Shafi-A., Simone-N. Temporal Considerations in Brain Metastases Radiation Therapy: The Intersection of Chronobiology and Patient Profiles. International Journal of Molecular Sciences (IJMS) and similar impact factor journals. CPDR

 

  1. Eaglehouse-Y., Darmon-S., Gage-M., Shriver-C., Zhu-K. Racial Comparisons in Treatment and Survival of Patients with Rectal Cancer in the U.S. Military Health System. Journal of the National Cancer Institute (JNCI). MCCRP 

 

  1. Su-X., Stopsack-K., Schmidt-D., Ma-D., Li-Z., Scheet-P., Penney-K., Lotan-T., Lu-K., DeArment-E., Janas-T., Heiden-M., Loda-M., Boselli-M., Amon-A., Mucci-L. RAD21 promotes oncogenesis and lethal progression of prostate cancer. Known research journals such as PNAS, Nature Communications, Cell Reports, Cancer Research, JCI Insight,  Cancer Research Communications, Molecular Cancer Research. CPDR

 

  1. Yanushko-D., German-B., El Bizri-R., Pervizou-D., Keime-C., Ye-T., Thibault-Carpentier-C., Henri-S., Laverny-G., Matzger-D. p53-loss induced prostatic epithelial cell plasticity and invasion driven by a crosstalk with the tumor microenvironment. CPDR

 

  1. Spencer-J., Liu-J., Deyarmin-B., Hu-H., Shriver-C., Somiari-S. Cytokine Levels in Breast Cancer are Highly Dependent on Cytomegalovirus (CMV) Status. CBCP

 

  1. Dew-A., Lin-J., Darmon-S., Roswarski-J., Shriver-C., Zhu-K., Chiu-A. Survival among Patients with Multiple Myeloma in the U.S .Military Health System Compared to the Surveillance, Epidemiology, and End Results (SEER) Program. MCCRP

 

  1. Kumar-P., Liu-J., Soltis-A., Bateman-N., Chen-Q., Sturtz-L., Deyarmin-B., Pierobon-M., Abulez-T., Kumar-AP., Zhang-X., Nguyen-T., Yan-C., Hu-Y., Guion-K., Hooke-J., Kovatich-A., Campbell-L., Mostoller-B., Kvecher-L., Somiari-S., Steeg-P., Rajagopal-S., Darcy-K., Lee-J., Dalgard-C., Conrads-T., Petricoin-E., Meerzaman-D., Wilkerson-M., APOLLO Research Network, Lin-X., Shriver-C., Lipkowitz-S., Hu-H. Proteogenomic characterization of invasive breast tumors in young women. CBCP

 

  1. Sadar-S. McNair-C., Ravindranath-L., Chand-S., Yuan-W., Bogdan-D., Welti-J., Sharp-A., Ryan-N., Schiewer-M., DeArment-E., Janas-T., Su-X., Butler-L., de Bono-J., Frese-K., Brooks-N., Pegg-N., Knudsen-K., Shafi-A. CBP/p300 are critical mediators of DNA repair in prostate cancer. CPDR

 

  1. Hill-A., Durbha-N., Eaglehouse-Y., Hong-Y., Xue-H. Equal Access, Unequal Outcomes? Racial Disparities in Mortality Between Black and White Women with Breast Cancer: A 10-Year Systematic Review and Meta-Analysis. MCCRP

 

MANUSCRIPT PUBLICATIONS (16)

  1. Kord, E., Jung, N., Posielski, N., Jiang, J., Elsamanoudi S., Chesnut, G., Speir, R., Stroup, S.,

Musser, J., Ernest, A., Tausch, T., Flores, JP., Porter, C. (2023). Prospective Long-term

Health-related Quality of Life Outcomes After Surgery, Radiotherapy, or Active Surveillance

for Localized Prostate Cancer. European Urology. 48, 60-69.

https://doi.org/10.1016/j.euros.2022.12.006. CPDR

 

  1. NCI. (January 2023). APOLLO Researchers Uncover Novel Proteogenomic Features of

Lung Cancer. Retrieved from

https://proteomics.cancer.gov/news_and_announcements/apollo-researchers-uncover-novel-

proteogenomic-features-lung-cancer. MCCRP

 

  1. Pence, S. T., Chesnut, G. T., & Shafi, A. A. (2023). Time Matters: Importance of Circadian

Rhythms, Disruption, and Chronotherapy in Urologic Malignancies. Urology, S0090-

4295(23)00052-3. Advance online publication.

https://doi.org/10.1016/j.urology.2023.01.009. CPDR

 

  1. Lovejoy LA, Shriver CD, Haricharan S, Ellsworth RE. Survival Disparities in US Black

Compared to White Women with Hormone Receptor Positive-HER2 Negative Breast

Cancer. International Journal of Environmental Research and Public Health. 2023;

20(4):2903. https://doi.org/10.3390/ijerph20042903. CBCP

 

  1. Boehm, B. E., York, M. E., Petrovics, G., Kohaar, I., & Chesnut, G. T. (2023). Biomarkers of

Aggressive Prostate Cancer at Diagnosis. International journal of molecular sciences, 24(3),

2185. https://doi.org/10.3390/ijms24032185. CPDR

 

  1. Darmon-S, Lovejoy-L, Shriver-C, Zhu-K, Ellsworth-R (2023). Nondisparate Survival of

Non-Hispanic Black Women With Breast Cancer Despite Less Favorable Pathology: Effect

of Access to and Provision of Care Within a Military Health Care System. Health Equity

178-184. http://doi.org/10.1089/heq.2022.0128. CBCP

 

  1. Jayakrishnan, R., Schafer, C., & Tan, S. H. (2023). Prostate cancer autoantibodies -

applications in diagnosis, prognosis, monitoring disease progression and

immunotherapy. American journal of clinical and experimental urology, 11(2), 79–102.

CPDR

 

  1. Schafer, C., Young, D., Singh, H., Jayakrishnan, R., Banerjee, S., Song, Y., Dobi, A.,

Petrovics, G., Srivastava, S., Srivastava, S., Sesterhenn, I. A., Chesnut, G. T., & Tan, S. H.

(2023). Development and characterization of an ETV1 rabbit monoclonal antibody for the

immunohistochemical detection of ETV1 expression in cancer tissue specimens. Journal of

immunological methods, 518, 113493. https://doi.org/10.1016/j.jim.2023.113493. CPDR

 

  1. Schafer C, Young D, Singh H, Jayakrishnan R, Banerjee S, Song Y, Dobi A, Petrovics G, Srivastava S, Srivastava S, Sesterhenn IA, Chesnut GT, Tan SH. Development and characterization of an ETV1 rabbit monoclonal antibody for the immunohistochemical detection of ETV1 expression in cancer tissue specimens. J Immunol Methods. 2023 Jul;518:113493. doi: 10.1016/j.jim.2023.113493. Epub 2023 May 16. PMID: 37196930. CPDR

 

  1. Eaglehouse YL, Shriver CD, Lin J, Bytnar JA, Darmon S, McGlynn KA, Zhu K. MilCanEpi: Increased Capability for Cancer Care Research in the Department of Defense. JCO Clin Cancer Inform. 2023 Aug;7:e2300035. doi: 10.1200/CCI.23.00035. PMID: 37582239; PMCID: PMC10569781. MCCRP

 

  1. Gordon N, Gallagher PT, Neupane NP, Mandigo AC, McCann JK, Dylgjeri E, Vasilevskaya I, McNair C, Paller CJ, Kelly WK, Knudsen KE, Shafi AA, Schiewer MJ. PARP inhibition and pharmacological ascorbate demonstrate synergy in castration-resistant prostate cancer. bioRxiv [Preprint]. 2023 Mar 23:2023.03.23.533944. doi: 10.1101/2023.03.23.533944. PMID: 36993449; PMCID: PMC10055378. CPDR

 

  1. Bowling GC, Swargaloganathan P, Heintz C, Madan RA, Eldhose B, Dobi A, Chesnut GT. Hematological Toxicities with PARP Inhibitors in Prostate Cancer: A Systematic Review and Meta-Analysis of Phase II/III Randomized Controlled Trials. Cancers (Basel). 2023 Oct 9;15(19):4904. doi: 10.3390/cancers15194904. PMID: 37835597; PMCID: PMC10571760. CPDR

 

  1. Lin-J., Shriver-C., Zhu-K. Survival among lung cancer patients: comparison of the U.S. military health system and the surveillance, epidemiology, and end results (SEER) program by health insurance status. Cancer Causes & Control (Journal). MCCRP

 

  1. Julie A. Bytnar, Lindsey Enewold, Craig D. Shriver, Kangmin Zhu, Incidence of papillary thyroid cancer: Comparison of the military and the general population by race and tumor stage/size, Cancer Epidemiology, Volume 89, 2024, 102539, ISSN 1877-7821, https://doi.org/10.1016/j.canep.2024.102539. MCCRP

 

  1. Eaglehouse YL, Darmon S, Gage MM, Shriver CD, Zhu K. Characteristics Associated With Survival in Surgically Nonresected Pancreatic Adenocarcinoma in the Military Health System. Am J Clin Oncol. 2024 Feb 1;47(2):64-70. doi: 10.1097/COC.0000000000001057. Epub 2023 Oct 17. PMID: 37851358; PMCID: PMC10805355. MCCRP

 

  1. Kumar-P., Lin-X., Liu-T., Sturtz-L., Gritsenko-M., Petyuk-V., Sagendorf-T., Deyarmin- B., Lui

J., Kumar-AP., Wang-G., McDermott-J., Shukla-A., Moore-R., Monroe-M.,

Webb-Robertson-BJ., Hooke-JA., Fantacone-Campbell-L., Mostoller-B., Kvecher-L.,

Kane-J., Melley-J., Somiari-S., Soon Shiong-P., Smith-R., Mural R., Rodland-K.,

Shriver-C., Kovatich-A., Hu, H. Proteogenomic characterization of non-luminal A versus

luminal A breast cancer tumor cells enriched by laser microdissection. Cancer Research

Journal of AACR. CBCP

 

POSTERS (43)

  1. Murtha-K., Kvecher-L., Mostoller-B., Wells-J., Kildee-M., Brockett-S., Campbell-L., Deyarmin-B., Shriver-C., Hu-H. Extraction and Submission of Clinical Data from a Customized Data Tracking System for Use in ORIEN Avatar. 2023 ORIEN Scientific Retreat. MCCRP

 

  1. Russo-M., Kumar-P., Liu-J., Deyarmin-B., Murthat-K., Wells-J., Wolf-N., Kovatich-A.,

Hooke-J., Campbell-L., Somiari-S., Kvecher-L., Hu-H., Shriver-C., Lin-X. Genomic and

Transcriptomic Analysis of Matched Metastatic Breast Cancer in a Multi-Network Cohort.

2023 ORIEN Scientific Retreat. MCCRP

 

  1.  Schafer-C., Young-D., Jiang-J., Song-Y., Dobi-A., Petrovics-G., Drake-B., Chesnut-G.,

Sesterhenn-I., Tan-SH. Immunohistochemical detection of ERG, ETV1, ETV4, and PTEN in

prostate tumor specimens reveals the heterogeneity of multi-focal prostate cancer. 2023

American Association for Cancer Research (AACR), Prostate Cancer Special Conference.

CPDR

 

  1.  Su-X., Stopsack-K., Schmidt-D., Ma-D., Li-Z., Vander Heiden-M., Amon-A., Mucci-L.

Increased RAD21 Promotes Prostate Cancer Development. 2023 American Association for

Cancer Research (AACR), Prostate Cancer Special Conference. CPDR

 

  1. Kohaar-I., Zhang-X., Tan-SH., Nousome-D., Babcock-K., Ravindranath-L., Sukumar-G.,

Mcgrath-Martinez-E., Rosenberger-J., Alba-C., Ali-A., Young-D., Chen-Y., Cullen-J.,

Rosner-I., Sesterhenn-I., Dobi-A., Chesnut-G., Turner-G., Turner-C., Dalgard-C., Wilkerson-

M., Pollard-H., Srivastava-S., Petrovics-G. Inherited mutations of DNA damage repair genes

in a racially diverse cohort of men with prostate cancer. 2023 American Association for

Cancer Research (AACR), Prostate Cancer Special Conference. CPDR

 

  1. Eldhose-B., Bowling-G., Beck-K., Malhotra-S., Pandrala-M., Su-X., Dobi-A. ERGi-USU

Selectively Inhibit ERG Positive Prostate Cancer through ATF3 mediated Ferroptosis. 2023

American Association for Cancer Research (AACR), Prostate Cancer Special Conference.

CPDR

 

  1. Lin-J, Shriver-C, Zhu-K. Post-diagnosis Statin use and Survival among Head and Neck

Cancer Patients: A Cohort Study in the U.S. Military Health System. 2023 American

Association for Cancer Research (AACR). MCCRP.

 

  1. Bytnar-J, Lin-J, Moncur-J,Shriver-C, Zhu-K. Cancers of unknown primary: Survival by

histologic type, demographic features, and treatment in the U.S. Military Health System.

2023 American Association for Cancer Research (AACR). MCCRP.

 

  1. Bytnar-J, Enewold-L, Shriver-C, Zhu-K. Incidence of papillary thyroid cancer: Comparison

of the military with the general population by gender, race, and tumor stage/size. 2023American Association for Cancer Research (AACR). MCCRP.

 

  1. Harmon-S., Patkar-S., Lis-R., McKenney-J., Merino-M., Young-D., Brown-T., Greenfield-

K., McGeeney-J., Elsamanoudi-S., Tan-SH., Jiang-J., Petrovics-G., Dobi-A., Rentas-F.,

Pinto-P., Chesnut-G., Choyke-P., TurkBey-B., Sesterhenn-I., Moncur-J. Development and

Clinical Outcome Evaluation of Cascaded AI algorithm for Cancer Detection and Grading in Prostate Cancer. 2023 USCAP. CPDR

 

  1.  Sardar-S., Ravindranath-L., McNair-C., Chand-S., Yuan-W., Bogdan-D., Welti-J., Sharp-A.,

Schiewer-M., Butler-L., de Bono-J., Frese-K., Brooks-N., Pegg-N., Knudsen-K., Shafi-A.

Targeting CBP/p300 and its downstream transcriptional machinery in advanced Pca. 2023 American Association for Cancer Research (AACR). CPDR

 

  1. Eldhose-B., Bowling-G., Beck-K., Malhotra-S., Pandrala-M., Su-X., Dobi-A. ERGi-USU

Selectively Inhibit ERG Positive Prostate Cancer through ATF3 mediated Ferroptosis. 2023

American Association for Cancer Research (AACR). CPDR

 

  1. Chand-NM, Tekumalla-P, Dobi-A, Ali-A, Miller-G, Aristizabal-Henoa-J, Granger-E,

Freedland-S,Srivastava, McLeod-D, Narain-N, Kiebish-M. Serum Filamin A is A Prognostic

Biomarker For Screening Benign Prostatic Hyperplasia VS Prostate Cancer in Caucasian and

African American Men. 2023 American Association for Cancer Research (AACR). CPDR

 

  1.  Wilkerson-M., Kounelis-Wuillaume-S., Alba-C., Franks-T., Doughty-M., Kortum-R.,

Browning-R., Dalgard-C., Shriver-C. Tumor microenvironment differences between lung

cancer subtypes revealed by spatial transcriptomics. 2023 American Association for Cancer

Research (AACR). MCCRP

 

  1. Jiang-L., Zhang-X., Alba-C., Sukumar-G., Rice-E., Wilkerson-M., Dalgard-C. The

Performance Characteristic of the Low Input Tagmentation-based Whole Genome

Sequencing in High Quality Somatic Variant Calling. 2023 American Association for Cancer

Research (AACR). MCCRP

 

  1. Kohaar-I., Wang-Y., Mamie Lih-TS, Höti-N., Sokoll-L., Chesnut-G., Petrovics-G., Zhang-H.

Differentially Expressed Glycoproteins in Pre - and Post-Digital Rectal Examination Urine

Samples for Detecting Aggressive Prostate Cancer. 2023 American Urology Association (AUA). CPDR

 

  1. Babcock-K., Kohaar-I., Petrovics-G., Chesnut-G., Tan-SH., Dobi-A. LSAMP Re-Expression

Inhibits Circulating Tumor Cell Burden in a Prostate Cancer Xenograft Model. 2023 USU

Research Day. CPDR

 

  1. Eldhose-B., Bowling-G., Beck-K., Malhotra-S., Pandrala-M., Su-X., Dobi-A. ERGi-USU

Selectively Inhibit ERG Positive Prostate Cancer through ATF3 mediated Ferroptosis. 2023

USU Research Day. CPDR

 

  1. Dinoto-K., Eldhose-B., Bowling-G., Beck-K., Malhotra-S., Pandrala-M., Su-X., Dobi-A.

ERGi-USU Selectively Inhibit ERG Positive Prostate Cancer through ATF3 mediated

Ferroptosis. 2023 USU Research Day. CPDR

 

  1. Borbiev-T., Bejar-K., Young-D., Song-Y, Jiang-J., Kagan-J., Srivastava-S., Hernandez-J.,

Chesnut-G., Sesterhenn-I., Leach-R., Petrovics-G., Kohaar-I. Prostate Cancer Biomarkers of

Biochemical Recurrence in Low-risk prostate Cancer patients. 2023 USU Research Day.

CPDR

 

  1. Eaglehouse-Y., Shriver-CD., Lin-J., Bytnar-J., Darmon-S., McGlynn-K., Zhu-K.

MilCanEpi: Increased Capability for Cancer Care Research in the Department of

Defense. 2023 Military Health System Research Symposium (MHSRS). MCCRP

 

  1. Seagal-A., Deyarmin-B., Ciubotaru-A., Blake-L., Murtha-K., Wells-J., Greenspan-R.,

Campbell-L., Stratton-J., Wolf-N., Shriver-C., Kvecher-L., Hu-H. Optimization and Data

Visualization of Applied Proteogenomics Organizational Learning and Outcomes

(APOLLO) Pathology Data. 2023 Military Health System Research Symposium

(MHSRS). MCCRP

 

  1. Shuss-S, Sturtz-L, Rummel-S, Blackburn-H, Kane-J, Cannada-M, Deyarmin-B, Miller-K,

Stratton-S, APOLLO Research Network, Shriver-C, Hu-H. Exploring Beyond Sample

Identification to Strengthen the Role of Molecular Quality Control in the APOLLO

Program. 2023 Military Health System Research Symposium (MHSRS). MCCRP

 

  1. Deyarmin-B, Blackburn-H, Miller-K, Kane-K, Cannada-M, Larson-C, Murtha-K,

Kvecher-L, Wolf-N, Kildee-M, Sakura-S, Wells-J, Hooke-J, Greenspan-R, Zingmark-R,

Hu-H, Shriver-C, Somiari-S. Murtha Cancer Center Research Program Efforts to Provide

Precision Medicine for the Military through Participation in the Oncology Research

Information Exchange Network (ORIEN). 2023 Military Health System Research

Symposium (MHSRS). MCCRP

 

  1.  Russo-M., Kumar-P., Liu-J., Deyarmin-B., Murthat-K., Wells-J., Wolf-N., Kovatich-A.,

Hooke-J., Campbell-L., Somiari-S., Kvecher-L., Hu-H., Shriver-C., Lin-X. Genomic and

Transcriptomic Analysis of Matched Metastatic Breast Cancer in a Multi-Network

Cohort. 2023 Military Health System Research Symposium (MHSRS). MCCRP

 

  1. Patkar-S., Harmon-S., Sesterhenn-I., Lis-R., Merino-M., Young-D., Brown-GT.,

Greenfield-K., McGeeney-J., Elsamanoudi-S., Tan-S., Jiang-J., Petrovics-G., Dobi-A.,

Rentas-F., Pinto-P., Chesnut-G., Choyke-P., Turkbey-B., Moncur-J. Development and

Clinical Outcome Evaluation of Cascaded AI algorithm for Cancer Detection and

Grading in Prostate Cancer. 2023 Military Health System Research Symposium

(MHSRS). CPDR

 

  1. Bowling-G., Malhorta-S., Pandrala-M., Su-X., Dobi-A., Eldhose-B. ERGi-USU

Selectively Inhibit ERG Positive Prostate Cancer through ATF3 mediated Ferroptosis.

2023 Military Health System Research Symposium (MHSRS). CPDR

 

  1. Boardley-A., Chao-N., Su-X., Dobi-A., Eldhose-B. ERGi-USU Selectively Inhibit ERG

Positive Prostate Cancer through ATF3 mediated Ferroptosis. USU Intern Poster

Presentation. CPDR

 

  1. Smith-M., Ravindranath-L., Shafi-A. The Circadian Cryptochrome, CRY1, Displays

Disease-Specific Functions in Prostate Cancer. 2023 GRC (Gordon Research

Conference) Hormone Dependent Cancers. CPDR

 

  1. Sardar-S., Ravindranath-L., McNair-C., Chand-S., Yuan-W., Bogdan-D., Welti-J., Sharp-

A., Schiewer-M., Butler-L., de Bono-J., Frese-K., Brooks-N., Pegg-N., Knudsen-K.,

Shafi-A. Targeting the CBP/p300 Axis Regulates DNA Damage Repair in Lethal Prostate

Cancer. 2023 GRC (Gordon Research Conference) Hormone Dependent Cancers. CPDR

 

  1. Janas-T., Stopsack-K. Schmidt-D., Ma-D., Li-Z., Heiden-M., Penny-K., Scheet-P.,

Lotan-T., Amon-A., Mucci-L., Su-X. Aneuploidy-associated SQLE gain promotes

prostate cancer aggressiveness by altering lipid metabolism. 2023 GRC (Gordon

Research Conference) Hormone Dependent Cancers. CPDR

 

  1. Petkovich-D., Koganti-P., German-B., Burkhart-D., Wu-P., Choudhury-A., Ellis-L. Targeting Therapy Resistant Phenotypic Plastic Prostate Cancer with Ataxia Telangiectasia and Rad3-Related (ATR) and DNA Methyltransferase Inhibitors. 2024 Prostate Specialized Program of Research Excellence (SPORE) Conference. CPDR

 

  1. Sadar-S., Ravindranath-L., McNair-C., Chand-S., Yuan-W., Bogdan-D., Welti-J., Sharp-A., Schiewer-M., Butler-K., de Bono-J., Frese-K., Brooks-N., Pegg-N., Knudsen-K., Shafi-S.  Targeting the CBP/p300 Axis in Castration Resistant Prostate Cancer Impacts DNA Damage Repair Function. 2024 Prostate Cancer SPORE Meeting – LA, California. CPDR

 

  1. Eaglehouse-Y., Darmon-S., Shriver-C., Zhu-K. Racial-Ethnic Comparisons in Treatment for Papillary Thyroid Cancer in an Equal Access Health System. American Association of Cancer Research (AACR) meeting. MCCRP

 

  1. Janas-T., Stopsack-K., Schmidt-D., Ma-D., Li-Z., Heiden-M., Penny-K., Scheet-P., Lotan-T., Amon-A., Mucci-L., Su-X. Aneuploidy-associated SQLE gain promotes prostate cancer aggressiveness by altering lipid metabolism. 2024 UCLA SPORE Conference. CPDR

 

  1. Liu-J., Lin-X., Shriver-C., Hu-H.  Treatment resistance and survival prediction using a machine learning gene expression signature in pancreatic adenocarcinoma. American Association for Cancer Research (AACR). MCCRP

 

  1. Sadar-S., Ravindranath-L., McNair-C., Chand-S., Yuan-W., Bogdan-D.Welti-J., Sharp-A., Schiewer-M.,  Butler-L., de Bono-J., Frese-K., Brooks-N., Pegg-N., Knudsen-K., Shafi-A. Targeting the CBP/p300 Axis in Castration Resistant Prostate Cancer Impacts DNA Damage Repair Function. American Association of Cancer Research (AACR) Annual 2024 Conference, San Diego, California. CPDR

 

  1. Schafer-C., Abulez-T., Zhang-X., Young-D., Fox-J., Conrads-K., Hood-B., Sukumar-G., Nousome-D., Shafi-A., Dobi-A., Petrovics-G., Ali-A., Jiang-J., Elsamanoudi-S., Cullen-J., Dalgard-C., Wilkerson-M.,  Bateman-N., Conrads-T., Sesterhenn-I., APOLLO Research Network, Shriver-C., Chesnut-G., Tan-S. Proteogenomic landscape of prostate cancers from patients of African and European ancestries highlight novel signatures of aggressive disease. American Association of Cancer Research (AACR) Annual 2024 Conference, San Diego, California. CPDR

 

  1. Janas-T., Stopsack-K., Schmidt-D., Ma-D., Li-Z., Vander Heiden-M., Penny-K., Scheet-P., Lotan-T., Amon-A., Mucci-L., Su-X. Aneuploidy-associated SQLE gain promotes prostate cancer aggressiveness by altering lipid metabolism. American Association of Cancer Research (AACR) Annual 2024 Conference, San Diego, California. CPDR

 

  1. German-B., Ko-A., Noel-T., Posadas-E., Knott-S., Priceman-S., Ellis-L. Studying the Role of Epigenetic Remodeling of the Myeloid Landscape in the Prostate Cancer Tumoral Microenvironment. USU Research Day 2024. CPDR

 

  1. Borbiev-T., Kohaar-I., Siddiqui-J., Chesnut-G., Petrovics-G., Wei-J. Urine Exosomal RNA Signatures Discriminate Gleason Groups at Initial Biopsy for Prostate Cancer. USU Research Day 2024. CPDR

 

  1. Borbiev-T., Kohaar-I., Siddiqui-J., Chesnut-G., Petrovics-G., Wei-J. Urine Exosomal RNA Signatures Discriminate Gleason Groups at Initial Biopsy for Prostate Cancer. 2024 Military Health System Research Symposium (MHSRS). CPDR

 

  1. Heredia-E., Patre-S., Paine-J., Chen-X., Lagerstrom-I., Jonsson-T., Matasci-N., Lombardo-J., Lee-J., Agus-D. An AI Research Platform for Computational Pathology. 10th Digital Pathology and AI Congress. MCCRP

 

 

ORAL PRESENTATION (5)

  1. Shriver-C. Murtha Cancer Center Research Program. AMSUS Health Equity Panel. MCCRP

 

  1. Shafi-A. Targeting CBP/p300 and its downstream transcriptional machinery in advanced Pca.

2023 American Association for Cancer Research (AACR), Prostate Cancer Special

Conference. CPDR

 

  1.  Su-X. Cohesin RAD21 is engaged at oncogenic transcription-coupled DNA lesions. DNA

Repair and Mutagenesis (DRAM) Seminar Series. CPDR

 

  1.  Shafi-A. The Circadian Clock and Prostate Cancer. ENDO 2023 (The Endocrine Society

Annual Meeting). CPDR

 

  1. Upadhyay-G. Outcome analysis of LY6 gene family in breast, pancreatic and ovarian

cancer. Immuno-Oncology Research Interest Group ORIEN Meeting, July 2023.

MCCRP

 

WEB HIGHLIGHT (2)

1. Schafer-C., Tan-S. Investigating Immunobiological Differences in Tumors from African

American and Caucasian American Men with Prostate Cancer. CDMRP website. CPDR

 

2. Shriver-CD., Lee-J., Casey-W., Vincent-Hall-TD., Borack-M. PROMETHEUS. VHA

Health Outcomes Military Exposures (HOME) quarterly (online) newsletter for

Veterans and families of recent conflicts. MCCRP

 

BOOK CHAPTERS/BOOKS (3)

1. Eldhose-B., Wilson-C. Role of Phospholipase A2 in Prostate Cancer. Elsevier Publications.

CPDR

 

2. Decastro-Pretelt-M., Ellsworth-R., Estrada-Veras-J., Shriver-C., Turner-C. Applying

Precision Medicine within a Learning Healthcare System for Military Service Members

MCCRP

 

3. Decastro-Pretelt-M., Ellsworth-R., Estrada-Veras-J., Shriver-C., Turner-C. Applying

Precision Medicine within a Learning Healthcare System for Military Service Members.

Oxford. MCCRP